- Report
- February 2024
- 137 Pages
Global
From €4756EUR$4,950USD£4,090GBP
- Report
- March 2024
- 187 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- October 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- March 2024
- 190 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- March 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 170 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- November 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- August 2023
- 220 Pages
Global
€4607EUR$4,795USD£3,962GBP
- Report
- April 2024
- 175 Pages
From €4804EUR$5,000USD£4,131GBP
The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats.
Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population.
Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more